D3.32 - China's Hypoallergenic Home Visit Program: A Standardized Process for Environmental Control Based on a Mobile Application

BackgroundEnvironmental factors significantly influence the development and progression of allergic diseases. With modern populations spending much more time indoors than outdoors, controlling the home environment is critical. This study explores a standardized process for home environmental control for allergic patients, facilitated by a mobile application.

MethodThe study introduces a new digital therapeutic model for allergic disease management: the Hypoallergenic Home Visit Program. Home visits were conducted for allergic patients to monitor allergens, assess environmental risks, and provide patient education. Through a mobile application and remote communication, patients were guided in allergy management. This approach integrates hospital-based primary care physicians with home-based management to establish a "hospital-home" allergy management system.

ResultsThe Hypoallergenic Home Visit Program involves assessing household allergens and air quality, providing environmental and behavioral intervention guidance, monitoring environmental conditions, and issuing warnings. Indoor dust mite allergens were monitored using rapid test kits to evaluate routine monitoring and control effectiveness. This program operationalized the concept of environmental therapy. Additionally, a mobile application was developed to manage allergic patients comprehensively, covering home visit scheduling, environmental data collection, disease follow-up, patient education, and indoor environment monitoring. The program establishes a "hospital-home" interactive allergy management model. Using semi-quantitative dust mite test kits, household air quality monitors, and sleep monitoring devices developed by the research team, the program digitized the collection of environmental and patient data, creating a digital twin for each patient.

ConclusionThe Hypoallergenic Home Visit Program, utilizing a mobile application and multiple environmental and physiological monitoring tools, represents the first complete practice of digital therapeutics for allergies in China. This initiative provides a novel reference for non-pharmacological treatments, environmental control, and digital therapeutics for allergic diseases.